<!DOCTYPE html><html><head><title>The Society of Thoracic Surgeons guidelines on the diagnosis and staging of patients with esophageal cancer.</title><link rel="stylesheet" type="text/css" href="style.css"></head><body><div class='section'>
<h2>General
</h2>
<div class='field field_text'>
<h3>
Guideline Title
</h3>
<div class='FieldValue'>
<div class="content_title">The Society of Thoracic Surgeons guidelines on the diagnosis and staging of patients with esophageal cancer.</div>
</div>

</div>
<div class='field field_citation'>
<h3>
Bibliographic Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Varghese TK Jr, Hofstetter WL, Rizk NP, Low DE, Darling GE, Watson TJ, Mitchell JD, Krasna MJ. The Society of Thoracic Surgeons guidelines on the diagnosis and staging of patients with esophageal cancer. Ann Thorac Surg. 2013 Jul;96(1):346-56. [78 references] <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=23752201" target="_blank">PubMed</a></td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the guideline.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Recommendations
</h2>
<div class='field field_text'>
<h3>
Major Recommendations
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The levels of evidence (<strong>A&ndash;C</strong>) and classification of recommendations (<strong>I&ndash;IV</strong>) are defined at the end of the "Major Recommendations" field.</p>
<p><strong>Diagnosis of Esophageal Cancer</strong></p>
<p><em>Class I Recommendation</em>: Flexible endoscopy with biopsy is the primary method for the diagnosis of esophageal carcinoma. <strong>(Level of Evidence B)</strong></p>
<p><strong>Staging of Esophageal Cancer</strong></p>
<p><strong>Note</strong>: For the remaining recommendations, the following definitions will be used: early stage cancer refers to nodular high-grade dysplasia or T1a as defined by endoscopic ultrasonography (EUS); locoregionalized esophageal cancer refers to esophageal cancers from T1b to T4, any N, and M0; and distant metastatic disease refers to M1 disease.</p>
<ul style="list-style-type: disc;">
    <li><em>Class I Recommendation</em>: For early stage esophageal cancer, computed tomography (CT) of the chest and abdomen is an optional test for staging. <strong>(Level of Evidence B)</strong> </li>
    <li><em>Class I Recommendation</em>: For locoregionalized esophageal cancer, CT of the chest and abdomen is a recommended test for staging. <strong>(Level of Evidence B)</strong> </li>
    <li><em>Class IIB Recommendation</em>: For early stage esophageal cancer, positron emission tomography (PET) is an optional test for staging. <strong>(Level of Evidence B)</strong> </li>
    <li><em>Class I Recommendation</em>: For locoregionalized esophageal cancer, PET is a recommended test for staging. <strong>(Level of Evidence B)</strong> </li>
    <li><em>Class IIA Recommendation</em>: In the absence of metastatic disease, EUS is recommended to improve the accuracy of clinical staging. <strong>(Level of Evidence B)</strong> </li>
    <li><em>Class IIA Recommendation</em>: Endoscopic mucosal resection (EMR) should be considered as a diagnostic/staging tool for small, discrete nodules or areas of dysplasia when the disease appears limited to the mucosa or submucosa as assessed by EUS. <strong>(Level of Evidence B)</strong> </li>
</ul>
<p><strong>Metastasis</strong></p>
<p><em>Class IIB Recommendation</em>: For locally advanced (T3/T4) adenocarcinoma of the esophagogastric junction infiltrating the anatomic cardia or Siewart type III esophagogastric tumors, laparoscopy is recommended to improve the accuracy of staging. <strong>(Level of Evidence C)</strong></p>
<p><span style="text-decoration: underline;"><strong>Definitions</strong></span>:</p>
<p><strong>Level of Evidence That Best Fits the Recommendation</strong></p>
<p><strong>Level A</strong>: Multiple populations evaluated. Data derived from multiple randomized clinical trials or meta-analyses.</p>
<p><strong>Level B</strong>: Limited populations evaluated. Data derived from a single randomized trial or non-randomized studies.</p>
<p><strong>Level C</strong>: Very limited populations evaluated. Only consensus opinion of experts, case studies, or standard of care are available.</p>
<p><strong>Classification of Recommendations</strong></p>
<p><strong>Class I (benefit &gt; &gt; &gt; risk)</strong>: Procedure/treatment SHOULD be performed/administered.</p>
<p><strong>Class IIA (benefit &gt; &gt; risk)</strong>: Additional studies with focused objectives needed. IT IS REASONABLE to perform procedure/administer treatment.</p>
<p><strong>Class IIB (benefit &gt; risk)</strong>: Additional studies with broad objectives needed; additional registry data would be helpful. Procedure/treatment MAY BE CONSIDERED.</p>
<p><strong>Class III (no benefit)</strong>: Procedure/test, not helpful. Treatment, no proven benefit.</p>
<p><strong>Class IV (harm)</strong>: Procedure, without benefit or harmful. Treatment, harmful to patients.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Clinical Algorithm(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>None provided</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Scope
</h2>
<div class='field field_text'>
<h3>
Disease/Condition(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Esophageal cancer</p></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Guideline Category
</h3>
<div class='FieldValue'>
Diagnosis
</div>
<div class='FieldValue'>
Evaluation
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Clinical Specialty
</h3>
<div class='FieldValue'>
Gastroenterology
</div>
<div class='FieldValue'>
Oncology
</div>
<div class='FieldValue'>
Pathology
</div>
<div class='FieldValue'>
Radiology
</div>
<div class='FieldValue'>
Thoracic Surgery
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Intended Users
</h3>
<div class='FieldValue'>
Advanced Practice Nurses
</div>
<div class='FieldValue'>
Physician Assistants
</div>
<div class='FieldValue'>
Physicians
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Objective(s)
</h3>
<div class='FieldValue'>
<ul style="list-style-type: disc;">
    <li>To systematically review the literature with regard to the diagnostic workup and staging of esophageal cancer </li>
    <li>To assist health-care providers in clinical decision-making by providing a range of acceptable approaches for the management of specific conditions </li>
</ul>
</div>

</div>
<div class='field field_text'>
<h3>
Target Population
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Patients at risk or with a diagnosis of esophageal cancer</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Interventions and Practices Considered
</h3>
<div class='FieldValue'>
<ol style="list-style-type: decimal;" start="1">
    <li>Flexible endoscopy with biopsy for diagnosis of esophageal carcinoma </li>
    <li>Staging of esophageal cancer:
    <ul style="list-style-type: disc;">
        <li>Computed tomography (CT) of the chest and abdomen </li>
        <li>Positron emission tomography (PET) </li>
        <li>Endoscopic ultrasonography (EUS) </li>
        <li>Endoscopic mucosal resection (EMR) </li>
        <li>Laparoscopy </li>
    </ul>
    </li>
</ol>
</div>

</div>
<div class='field field_text'>
<h3>
Major Outcomes Considered
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Sensitivity, specificity, and accuracy of diagnostic studies</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Methodology
</h2>
<div class='field field_picklist-many'>
<h3>
Methods Used to Collect/Select the Evidence
</h3>
<div class='FieldValue'>
Hand-searches of Published Literature (Primary Sources)
</div>
<div class='FieldValue'>
Hand-searches of Published Literature (Secondary Sources)
</div>
<div class='FieldValue'>
Searches of Electronic Databases
</div>

</div>
<div class='field field_text'>
<h3>
Description of Methods Used to Collect/Select the Evidence
</h3>
<div class='FieldValue'>
<div class="content_para"><p>For this systematic review on the diagnosis and staging of esophageal cancer, specific search terms were identified and targeted searches were run in PubMed/MEDLINE, EMBASE, and the Cochrane databases in June 2011. The results were limited to publications since 1990, and human subjects. The authors augmented the computerized literature search by manually reviewing the reference lists of identified studies and relevant reviews. In addition, the writing group identified articles from personal files. The following three medical subject heading (MeSH) terms were used: "esophageal neoplasms," "early detection of cancer," and "neoplasm staging." Additional search strategies incorporated the MeSH subheadings of "analysis," "anatomy and histology," "classification," "diagnosis," "diagnostic use," "histology," "methods," "pathology," "standards," "trends," "ultrasonography," "positron emission tomography," and "trends."</p>
<p>In all, 4,064 articles and abstracts were identified through the initial EMBASE search, and 2,874 articles were identified through PubMed/MEDLINE. The Cochrane database identified 2 additional reviews and 191 clinical trials. Abstracts were reviewed by at least two authors and excluded if data were duplicative, not specifying esophageal cancer, purely descriptive, or incomplete. The resulting 80 articles served as the source for the review; 46 are cited and the remaining are listed in the appendix in the original guideline document.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Number of Source Documents
</h3>
<div class='FieldValue'>
<div class="content_para"><p>80 articles served as the source for the review.</p></div>
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Methods Used to Assess the Quality and Strength of the Evidence
</h3>
<div class='FieldValue'>
Weighting According to a Rating Scheme (Scheme Given)
</div>

</div>
<div class='field field_text'>
<h3>
Rating Scheme for the Strength of the Evidence
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Level of Evidence That Best Fits the Recommendation</strong></p>
<p><strong>Level A</strong>: Multiple populations evaluated. Data derived from multiple randomized clinical trials or meta-analyses.</p>
<p><strong>Level B</strong>: Limited populations evaluated. Data derived from a single randomized trial or non-randomized studies.</p>
<p><strong>Level C</strong>: Very limited populations evaluated. Only consensus opinion of experts, case studies, or standard of care are available.</p></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Methods Used to Analyze the Evidence
</h3>
<div class='FieldValue'>
Review of Published Meta-Analyses
</div>
<div class='FieldValue'>
Systematic Review
</div>

</div>
<div class='field field_text'>
<h3>
Description of the Methods Used to Analyze the Evidence
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Not stated</p></div>
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Methods Used to Formulate the Recommendations
</h3>
<div class='FieldValue'>
Expert Consensus
</div>

</div>
<div class='field field_text'>
<h3>
Description of Methods Used to Formulate the Recommendations
</h3>
<div class='FieldValue'>
<div class="content_para"><p>A task force was assembled through the Workforce on Evidence Based Surgery and the General Thoracic Surgery Workforce of the Society of Thoracic Surgeons (STS) with the goal of addressing the factors affecting the treatment of localized esophageal cancer.</p>
<p>Guideline recommendations were formulated and reviewed by all members of the writing group before approval by the Workforce on Evidence Based Surgery and the STS Executive Committee.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Rating Scheme for the Strength of the Recommendations
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Classification of Recommendations</strong></p>
<p><strong>Class I (benefit &gt; &gt; &gt; risk)</strong>: Procedure/treatment SHOULD be performed/administered.</p>
<p><strong>Class IIA (benefit &gt; &gt; risk)</strong>: Additional studies with focused objectives needed. IT IS REASONABLE to perform procedure/administer treatment.</p>
<p><strong>Class IIB (benefit &gt; risk)</strong>: Additional studies with broad objectives needed; additional registry data would be helpful. Procedure/treatment MAY BE CONSIDERED.</p>
<p><strong>Class III (no benefit)</strong>: Procedure/test, not helpful. Treatment, no proven benefit.</p>
<p><strong>Class IV (harm)</strong>: Procedure, without benefit or harmful. Treatment, harmful to patients.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Cost Analysis
</h3>
<div class='FieldValue'>
<div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div>
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Method of Guideline Validation
</h3>
<div class='FieldValue'>
Internal Peer Review
</div>

</div>
<div class='field field_text'>
<h3>
Description of Method of Guideline Validation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Guideline recommendations were reviewed by all members of the writing group before approval by the Workforce on Evidence Based Surgery and the Society of Thoracic Surgeons (STS) Executive Committee.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting the Recommendations
</h2>
<div class='field field_text'>
<h3>
Type of Evidence Supporting the Recommendations
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The type of supporting evidence is identified and graded for each recommendation (see the "Major Recommendations" field).</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Benefits/Harms of Implementing the Guideline Recommendations
</h2>
<div class='field field_text'>
<h3>
Potential Benefits
</h3>
<div class='FieldValue'>
<ul style="list-style-type: disc;">
    <li>Appropriate diagnosis and staging of patients with esophageal cancer </li>
    <li>There is increasing evidence that multimodality therapy (neoadjuvant chemotherapy or radiation therapy, or both, followed by esophagectomy) has increased survival benefits when compared with surgery alone for more advanced stages. Accurate staging information is thus critical for the determination of appropriate therapeutic intervention. </li>
</ul>
</div>

</div>
<div class='field field_text'>
<h3>
Potential Harms
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Endoscopic Ultrasonography</strong></p>
<p>As endoscopic ultrasound probes are typically larger in size, care should be used when attempting biopsies in the setting of stricture, in particular when dilating the tumor stricture.</p>
<p><strong>Diagnostic Endoscopic Mucosal Resection</strong></p>
<p>Perforation risk and bleeding risk are the most relevant and range from less than 1% to 2%, respectively.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Qualifying Statements
</h2>
<div class='field field_text'>
<h3>
Qualifying Statements
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The Society of Thoracic Surgeons Clinical Practice Guidelines are intended to assist physicians and other health care providers in clinical decision making by describing a range of generally acceptable approaches for the diagnosis, management, or prevention of specific diseases or conditions. These guidelines should not be considered inclusive of all proper methods of care or exclusive of other methods of care reasonably directed at obtaining the same results. Moreover, these guidelines are subject to change over time, without notice. The ultimate judgment regarding the care of a particular patient must be made by the physician in light of the individual circumstances presented by the patient.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Implementation of the Guideline
</h2>
<div class='field field_text'>
<h3>
Description of Implementation Strategy
</h3>
<div class='FieldValue'>
<div class="content_para"><p>An implementation strategy was not provided.</p></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Implementation Tools
</h3>
<div class='FieldValue'>
Chart Documentation/Checklists/Forms
</div>

</div>

</div>
<div class='section'>
<h2>Institute of Medicine (IOM) National Healthcare Quality Report Categories
</h2>
<div class='field field_picklist-many'>
<h3>
IOM Care Need
</h3>
<div class='FieldValue'>
Getting Better
</div>
<div class='FieldValue'>
Living with Illness
</div>

</div>
<div class='field field_picklist-many'>
<h3>
IOM Domain
</h3>
<div class='FieldValue'>
Effectiveness
</div>

</div>

</div>
<div class='section'>
<h2>Identifying Information and Availability
</h2>
<div class='field field_citation'>
<h3>
Bibliographic Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Varghese TK Jr, Hofstetter WL, Rizk NP, Low DE, Darling GE, Watson TJ, Mitchell JD, Krasna MJ. The Society of Thoracic Surgeons guidelines on the diagnosis and staging of patients with esophageal cancer. Ann Thorac Surg. 2013 Jul;96(1):346-56. [78 references] <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=23752201" target="_blank">PubMed</a></td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Adaptation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Date Released
</h3>
<div class='FieldValue'>
2013 Jul
</div>

</div>
<div class='field field_orglist-p'>
<h3>
Guideline Developer(s)
</h3>
<div class='FieldValue'>
Society of Thoracic Surgeons - Medical Specialty Society
</div>

</div>
<div class='field field_text'>
<h3>
Source(s) of Funding
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Society of Thoracic Surgeons</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Committee
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Society of Thoracic Surgeons Workforces on Evidence Based Surgery and General Thoracic Surgery</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Composition of Group That Authored the Guideline
</h3>
<div class='FieldValue'>
<div class="content_para"><p><em>Workforce Members</em>: Thomas K. Varghese, Jr, MD, MS; Wayne L. Hofstetter, MD; Nabil P. Rizk, MD; Donald E. Low, MD; Gail E. Darling, MD; Thomas J. Watson, MD; John D. Mitchell, MD; Mark J. Krasna, MD</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Financial Disclosures/Conflicts of Interest
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Drs. Varghese, Hofstetter, Rizk, Low, Darling, Watson, Mitchell, and Krasna have no conflicts of interest to declare regarding this work.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the guideline.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Availability
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Electronic copies: Available from the <a href="http://www.sts.org/publications-resources/guidelines/diagnosis-and-staging-patients-esophageal-cancer" title="Society of Thoracic Surgeons Web site">Society of Thoracic Surgeons Web site</a>.</p>
<p>Print copies: Available from The Society of Thoracic Surgeons, 633 N. Saint Clair St., Suite 2320, Chicago, IL, USA 60611-3658</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Availability of Companion Documents
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Elements considered critical for an endoscopy report for esophageal cancer, including a template for upper gastrointestinal endoscopy for esophageal cancer to initially stage esophageal or gastroesophageal junction carcinoma and templates for recording findings from endoscopic ultrasonography and endoscopic mucosal resection, can be found in the <a href="http://www.sts.org/publications-resources/guidelines/diagnosis-and-staging-patients-esophageal-cancer" title="Society of Thoracic Surgeons Web site">original guideline document</a>.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Patient Resources
</h3>
<div class='FieldValue'>
<div class="content_para"><p>None available</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
NGC Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NGC summary was completed by ECRI Institute on October 22, 2013.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Copyright Statement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>&copy; 2013 The Society of Thoracic Surgeons</p>
<p>The Society of Thoracic Surgeons Practice Guidelines may be printed or downloaded for individual and personal use only. Guidelines may not be reproduced in any print or electronic publication or offered for sale or distribution in any format without the express written permission of the Society of Thoracic Surgeons.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Disclaimer
</h2>
<div class='field field_text'>
<h3>
NGC Disclaimer
</h3>
<div class='FieldValue'>
<p>The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p>
</div>

</div>

</div>
</body></html>